Gynecological Oncology: Personalized Diagnosis and Therapy

Dear Colleagues,

The treatment of gynaecological cancers has, in recent years, seen a transformation away from universal radical extirpative surgery, non-conformal radiotherapy techniques, and a default reliance on platinum-based chemotherapy agents to a wide range of precision medical and surgical interventions, individually targeting both the patient and their cancer. Individualised treatment decisions are as important in cancer prophylaxis and detection as they are in targeting treatment based on patient preference and tumour characteristics.

From vaccination and screening for cervical dysplasia and cancer through HPV DNA and RNA techniques to informing drug therapies and prophylactic surgery in endometrial cancer and ovarian cancer, genomic medicine is driving the personalisation of targeted cancer prevention and treatments. For those with advanced cancer, stratification into prehabilitation programmes prior to treatments is helping to ensure robust patient selection for the most radical or toxic of therapies.

In an effort to provide quality precision treatments in gynaecological cancer, innovation and challenges have been critical to informing larger-scale evidence. This Special Issue welcomes submissions that contain original research in the translational and clinical domains or review articles that demonstrate innovation towards the personalisation of gynaecological cancer detection, prevention, and treatment across surgical, radiation, and medical oncology fields and palliative medicine.

Dr. Stuart Rundle
Dr. Ali Kucukmetin
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• gynaecologic oncology
• surgical oncology
• medical oncology
• radiation oncology
• clinical oncology
• palliative medicine
• diagnosis
• translational research
• stratification
• patient selection
• genomics